EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?

Miriam Dellino iD, Marco Cerbone iD, Antonio Simone Laganà iD, Amerigo Vitagliano iD, Antonella Vimercati iD, Marco Marinaccio, Giorgio Maria Baldini iD, Antonio Malvasi, Ettore Cicinelli iD, Gianluca Raffaello Damiani iD, Gerardo Cazzato iD, Eliano Cascardi iD

International Journal of Molecular Sciences · 05.06.2023 · 24 (11) · 9780

DOI: 10.3390/ijms24119780 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.06.2023. Verfasst von Miriam Dellino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynaecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Fertility Preservation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One emerging problem for onco-gynecologists is the incidence of premenopausal patients under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to preserve their fertility. Our review aims to define a primary risk assessment that can help fertility experts and onco-gynecologists tailor personalized treatment and fertility-preserving strategies for fertile patients wishing to have children. We confirm that risk factors such as myometrial invasion and The International Federation of Gynecology and Obstetrics (FIGO) staging should be integrated into the novel molecular classification provided by The Cancer Genome Atlas (TCGA). We also corroborate the influence of classical risk factors such as obesity, Polycystic ovarian syndrome (PCOS), and diabetes mellitus to assess fertility outcomes. The fertility preservation options are inadequately discussed with women with a diagnosis of gynecological cancer. A multidisciplinary team of gynecologists, oncologists, and fertility specialists could increase patient satisfaction and improve fertility outcomes. The incidence and death rates of endometrial cancer are rising globally. International guidelines recommend radical hysterectomy and bilateral salpingo-oophorectomy as the standard of care for this cancer; however, fertility-sparing alternatives should be tailored to motivated women of reproductive age, establishing an appropriate cost–benefit balance between childbearing desire and cancer risk. New molecular classifications such as that of TCGA provide a robust supplementary risk assessment tool that can tailor the treatment options to the patient’s needs, curtail over- and under-treatment, and contribute to the spread of fertility-preserving strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsFertility PreservationPregnancyChildFemaleHumansHysterectomyPreservation, BiologicalRisk Factors

Stichwörter der Autor:innen

endometrial cancerfertility preservationmolecular characterizationreproductive outcome

Autor:innen und Institutionen

  • Obstetrics and Gynaecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.
  • Unit of Gynecologic Oncology, ARNAS "Civico-Di Cristina-Benfratelli", Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Ita…
  • MOMO' FertiLIFE IVF Center, 76011 Bisceglie, Italy.
  • Department of Emergency and Organ Transplantation, Pathology Section, University of Bari "Aldo Moro", 70124 Bari, Italy.
  • Department of Medical Sciences, University of Turin, 10124 Turin, Italy.
  • Pathology Unit, FPO-IRCCS Candiolo Cancer Institute, 10060 Candiolo, Italy.

ORCID-Profile: Miriam Dellino, Marco Cerbone, Antonio Simone Laganà, Amerigo Vitagliano, Antonella Vimercati, Giorgio Maria Baldini, Ettore Cicinelli, Gianluca Raffaello Damiani, Gerardo Cazzato, Eliano Cascardi

Zitieren

APA

Dellino, M., Cerbone, M., Laganà, A. S., Vitagliano, A., Vimercati, A., Marinaccio, M., Baldini, G. M., Malvasi, A., Cicinelli, E., Damiani, G. R., Cazzato, G., & Cascardi, E. (2023). Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?. International Journal of Molecular Sciences, 24(11), 9780. https://doi.org/10.3390/ijms24119780

Vancouver

Dellino M, Cerbone M, Laganà AS, Vitagliano A, Vimercati A, Marinaccio M, et al. Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?. International Journal of Molecular Sciences. 2023;24(11):9780. doi:10.3390/ijms24119780

BibTeX
@article{Dellino2023,
  author = {Dellino, Miriam and Cerbone, Marco and Laganà, Antonio Simone and Vitagliano, Amerigo and Vimercati, Antonella and Marinaccio, Marco and Baldini, Giorgio Maria and Malvasi, Antonio and Cicinelli, Ettore and Damiani, Gianluca Raffaello and Cazzato, Gerardo and Cascardi, Eliano},
  title = {Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer—Driving New Tools for Endometrial Preservation?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {9780},
  doi = {10.3390/ijms24119780}
}
Kostenlos starten →